Internal Medicine, Cardiovascular Disease · Tallahassee, FL
NPI
1700194966
Since 2010
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1300 Medical Dr
Tallahassee, FL, 32308
Phone (850) 216-0100
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
3,085 services
Medicare patients, 2024
1,107
Average age 77
Drug cost, 2024
$14.1M
16,910 prescriptions
Company payments, 2025
$31K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gian-Carlo Giove was code 99215 (office e&m - established), 459 times for 234 patients. In total Gian-Carlo Giove billed 3,085 services in 67 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 459 | 234 | $138.76 | $64K |
| 93010 Electrocardiogram | Facility | 444 | 380 | $6.71 | $2,979 |
| 93306 Echocardiography (TTE/TEE) | Office | 250 | 243 | $147.59 | $37K |
| 93306 Echocardiography (TTE/TEE) | Facility | 176 | 175 | $55.72 | $9,806 |
| 99233 Hospital E&M - Subsequent | Facility | 142 | 88 | $98.79 | $14K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 133 | 34 | $5.44 | $724 |
| 99223 Hospital E&M - Initial | Facility | 120 | 115 | $143.41 | $17K |
| J1940 Injection, furosemide, up to 20 mg | Office | 114 | 24 | $0.42 | $47.93 |
| Q9957 Injection, perflutren lipid microspheres, per ml | Office | 101 | 56 | $32.54 | $3,287 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 88 | 44 | $104.43 | $9,190 |
| 78452 Myocardial Perfusion Scan | Facility | 78 | 78 | $60.08 | $4,686 |
| 99214 Office E&M - Established | Office | 75 | 70 | $104.65 | $7,849 |
| 36415 Venipuncture Blood Collection | Office | 62 | 45 | $8.65 | $536 |
| 93000 Electrocardiogram | Office | 47 | 46 | $10.96 | $515 |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 45 | 45 | $32.03 | $1,442 |
By year: 2022 $231K for 3,309 services; 2023 $205K for 3,205 services; 2024 $220K for 3,085 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 62 | 45 | $8.65 | $536 |
| 83880 Clinical Chemistry | 42 | 30 | $38.47 | $1,616 |
Medicare prescription drug claims, 2024
In 2024, the drug Gian-Carlo Giove prescribed most often to Medicare patients was Spironolactone, with 1,460 prescriptions and refills. In total Gian-Carlo Giove wrote 16,910 Medicare prescriptions that cost $14.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 1,460 | 2,673 | 429 | $9,493 |
| Metoprolol Succinate Generic | 1,344 | 2,544 | 359 | $20K |
| Entresto Sacubitril/Valsartan | 1,034 | 1,410 | 204 | $908K |
| Jardiance Empagliflozin | 1,009 | 1,357 | 213 | $780K |
| Torsemide Generic | 920 | 1,629 | 298 | $18K |
| Furosemide Generic | 829 | 1,532 | 273 | $3,959 |
| Farxiga Dapagliflozin Propanediol | 797 | 1,196 | 185 | $657K |
| Atorvastatin Calcium Generic | 791 | 1,691 | 232 | $7,544 |
| Potassium Chloride Generic | 769 | 1,315 | 270 | $12K |
| Rosuvastatin Calcium Generic | 687 | 1,457 | 171 | $8,397 |
| Carvedilol Generic | 672 | 1,337 | 169 | $5,782 |
| Losartan Potassium Generic | 603 | 1,223 | 166 | $5,699 |
| Eliquis Apixaban | 449 | 609 | 116 | $348K |
| Lisinopril Generic | 376 | 770 | 114 | $2,261 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 360 | 652 | 95 | $3,840 |
Brand drugs: - claims; generic drugs: 11,811 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gian-Carlo Giove $31K ($31K in general payments such as food, travel and fees) from 27 companies. The largest payer was BridgeBio Pharma, Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. BBIO | 13 | $11K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 20 | $9,953 |
| Pfizer Inc. PFE | 19 | $3,402 |
| Lilly USA, LLC LLY | 1 | $880 |
| AstraZeneca Pharmaceuticals LP AZN | 25 | $736 |
| Alnylam Pharmaceuticals Inc. ALNY | 22 | $654 |
| AOP Health US, LLC | 2 | $633 |
| CVRx, Inc. CVRX | 3 | $469 |
| Medtronic, Inc. MDT | 5 | $457 |
| Novartis Pharmaceuticals Corporation NVS | 30 | $449 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.